Back to Trades
Buy4
Kailera Therapeutics, Inc.
KLRA
Total Value
$8.0M
Net $8.0M bought
Purchases
$8.0M
1 transaction
Company Information
- Company Name
- Kailera Therapeutics, Inc.
- Ticker Symbol
- KLRA
- CIK
- 0002096997
Insider Information
- Role
- Insider
- Location
- NEW YORK, NY
Filing Details
- Filing Date
- Apr 22, 2026
- Transaction Date
- Apr 20, 2026
- Accession Number
- 0001231919-26-000390
- Form Type
- 4
- Net Trading Amount
- $8.0M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 20, 2026 | Common Stock | 10,276,820 | — | C | — |
| Apr 20, 2026 | Common Stock | 500,000 | $16.00 | Purchase | $8.0M |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 20, 2026 | Derivative | 8,250,000 | — | C | — |
| Apr 20, 2026 | Derivative | 2,026,820 | — | C | — |
Footnotes
- (F1)Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-1 basis and had no expiration date.
- (F2)Held by certain affiliated funds managed by RTW Investments, LP ("RTW"). Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW. The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their pecuniary interest therein.